BACKGROUND: Studies has demonstrated that transforming growth factor β1(TGF-β1) eyedrops is not only involved in the tissue metabolism of normal eye as well as kinds of physiological function, but also plays an important role in the treatment effect on corneal wound healing, uveitis and nearsightedness .
OBJECTIVE: To investigate the concentration of TGF-β1 in aqueous humor after ophthalmic administration and to establish the method for quantitatively analyzing the TGF-β1 levels in rabbit aqueous humor.
METHODS: Thirty rabbits were randomly divided into blank control, TGF-β1 0.5, 1.0, 2.0, 4.0 mg/L groups, with six animals in each group. PBS and 0.5, 1.0, 2.0,4.0 mg/L TGF-β1 were dropped into the right eyeballs four times per day for 1 week.
RESULTS AND CONCLUSION: No conjunctival secretion, bulbar conjunctiva hyperemia, corneal edema, keratic precipitates, inflammation in anterior chamber, or vitreous haze lens opacity was found prior to and following experiments in each group. ELISA results showed that compared with PBS, both 2.0 mg/L and 4.0 mg/L TGF-β1 eyedrops can significantly improve the TGF-β1 concentration effectively in rabbit aqueous humor (P < 0.05), which has a good penetrating ability in the cornea, and can effectively enhance treatment concentration in aqueous humor.